| scholarly article | Q13442814 |
| P356 | DOI | 10.1002/MDS.25877 |
| P698 | PubMed publication ID | 24919813 |
| P2093 | author name string | Eli Eyal | |
| Robert A Hauser | |||
| Dee Silver | |||
| Stuart Isaacson | |||
| Azhar Choudhry | |||
| ANDANTE study investigators | |||
| P433 | issue | 8 | |
| P921 | main subject | Parkinson's disease | Q11085 |
| rasagiline | Q420685 | ||
| randomized controlled trial | Q1436668 | ||
| P304 | page(s) | 1028-1034 | |
| P577 | publication date | 2014-06-11 | |
| P1433 | published in | Movement Disorders | Q1486418 |
| P1476 | title | Randomized, controlled trial of rasagiline as an add-on to dopamine agonists in Parkinson's disease | |
| P478 | volume | 29 |
| Q64869056 | A multiple treatment comparison meta-analysis of monoamine oxidase type B inhibitors for Parkinson's disease |
| Q30240991 | A systematic review of the literature on disorders of sleep and wakefulness in Parkinson's disease from 2005 to 2015. |
| Q38817972 | Clinical Pharmacokinetics and Pharmacodynamics of Safinamide |
| Q38545359 | Defining the Role of the Monoamine Oxidase-B Inhibitors for Parkinson's Disease |
| Q40680514 | Early Parkinson's disease patients on rasagiline present with better odor discrimination |
| Q33765388 | Efficacy of antidepressive medication for depression in Parkinson disease: a network meta-analysis |
| Q26740905 | Emerging approaches in Parkinson's disease - adjunctive role of safinamide |
| Q35599297 | How to optimize the treatment of early stage Parkinson's disease |
| Q52806941 | Monoamine oxidase-B inhibitors in the treatment of Parkinson's disease: clinical-pharmacological aspects. |
| Q51287697 | Pharmacokinetics of Rasagiline in Healthy Adult Chinese Volunteers with Various Genotypes: A Single-Center, Open-Label, Multiple-Dose Study. |
| Q33708918 | Phase IIb Study of Intranasal Glutathione in Parkinson's Disease |
| Q38260834 | Rasagiline: a review of its use in the treatment of idiopathic Parkinson's disease |
Search more.